Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LAPATINIB DITOSYLATE Cause Weight decreased? 108 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 108 reports of Weight decreased have been filed in association with LAPATINIB DITOSYLATE (Lapatinib). This represents 2.7% of all adverse event reports for LAPATINIB DITOSYLATE.

108
Reports of Weight decreased with LAPATINIB DITOSYLATE
2.7%
of all LAPATINIB DITOSYLATE reports
9
Deaths
21
Hospitalizations

How Dangerous Is Weight decreased From LAPATINIB DITOSYLATE?

Of the 108 reports, 9 (8.3%) resulted in death, 21 (19.4%) required hospitalization, and 3 (2.8%) were considered life-threatening.

Is Weight decreased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LAPATINIB DITOSYLATE. However, 108 reports have been filed with the FAERS database.

What Other Side Effects Does LAPATINIB DITOSYLATE Cause?

Diarrhoea (893) Death (665) Nausea (317) Fatigue (301) Vomiting (259) Rash (249) Drug ineffective (183) Malignant neoplasm progression (183) Off label use (141) Disease progression (137)

What Other Drugs Cause Weight decreased?

ADALIMUMAB (9,387) INFLIXIMAB (5,612) METHOTREXATE (5,432) SACUBITRIL\VALSARTAN (5,030) RITUXIMAB (4,866) APREMILAST (4,692) PREDNISONE (4,351) LENALIDOMIDE (4,235) ETANERCEPT (3,609) SEMAGLUTIDE (3,518)

Which LAPATINIB DITOSYLATE Alternatives Have Lower Weight decreased Risk?

LAPATINIB DITOSYLATE vs LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN LAPATINIB DITOSYLATE vs LARONIDASE LAPATINIB DITOSYLATE vs LAROTRECTINIB LAPATINIB DITOSYLATE vs LASILIX LAPATINIB DITOSYLATE vs LASIX

Related Pages

LAPATINIB DITOSYLATE Full Profile All Weight decreased Reports All Drugs Causing Weight decreased LAPATINIB DITOSYLATE Demographics